{"id":18318,"date":"2015-12-21T14:00:09","date_gmt":"2015-12-21T13:00:09","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=18318"},"modified":"2015-12-21T14:00:09","modified_gmt":"2015-12-21T13:00:09","slug":"que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/","title":{"rendered":"\u00bfQu\u00e9 puede aportar la tecnolog\u00eda al cumplimiento de los tratamientos? Entrevista a Eran Shavelsky, fundador de Medminder"},"content":{"rendered":"<div align=\"center\">\n<p><iframe src=\"https:\/\/player.vimeo.com\/video\/149628985\" height=\"281\" width=\"500\" allowfullscreen=\"\" frameborder=\"0\"><\/iframe><\/p>\n<div align=\"\/center\">\n<p style=\"text-align: left;\"><strong>M\u00e1s de 21.500 personas se benefician en Barcelona de los Sistemas Personalizados de Dosificaci\u00f3n que ofrecen las farmacias<\/strong>. <strong>\u00bfQu\u00e9 podr\u00eda aportar la tecnolog\u00eda a estos dispositivos?<\/strong> \u00c9sta es una de las preguntas a las que respondi\u00f3 Eran Shavelsky, fundador y CEO de Medminder, en la entrevista que le hicimos al Colegio, aprovechando su visita a Barcelona el pasado mes de octubre.<\/p>\n<p style=\"text-align: left;\"><strong>En Estados Unidos la empresa ha desarrollado unos dispositivos electr\u00f3nicos con la misma finalidad que los SPD, pero contando con el soporte de la tecnolog\u00eda<\/strong>. Con el objetivo de garantizar que los usuarios sigan el tratamiento correctamente estos \u201cdispensadores de p\u00edldoras\u201d, tal y como los definen, incorporan alertas tanto visuales como sonoras, y otros sistemas de aviso, por ejemplo grabaciones de voz que pueden programar los familiares, incluso, telem\u00e1ticamente. Adem\u00e1s, permite realizar el seguimiento online de c\u00f3mo se est\u00e1 tomando el paciente el tratamiento y detectar si ha habido olvidos y en qu\u00e9 momento.<\/p>\n<p style=\"text-align: left;\">Entre los principales beneficios, Shavelsky explica que con este sistema han logrado una \u201c<strong>tasa de cumplimiento del 95%\u201d <\/strong>por parte de los pacientes que lo utilizan, <strong>&quot;se ahorran hospitalizaciones&quot; y se ayuda a &quot;mantener su independencia&quot;<\/strong>.<\/p>\n<p style=\"text-align: left;\">\u00bfC\u00f3mo podr\u00edan beneficiarse los pacientes en Catalu\u00f1a? \u00bfQui\u00e9n estar\u00eda dispuesto a apostar por este servicio? \u00bfQu\u00e9 podr\u00eda aportar a los farmac\u00e9uticos? \u00c9stas son algunas de las preguntas que le formul\u00f3 el tesorero del Colegio, Joan Calduch, al ide\u00f3logo de estos dispositivos para poder compartir su experiencia con vosotros.<strong> Encontrar\u00e1 todas las respuestas en este <a href=\"https:\/\/vimeo.com\/149628985\" target=\"_blank\" rel=\"noopener\">v\u00eddeo<\/a><\/strong>.<\/p>\n<p style=\"text-align: left;\"><span style=\"color: #808080;\">Los\u00a0<strong>Sistemas Personalizados de Dosificaci\u00f3n (SPD)<\/strong>\u00a0permiten organizar la medicaci\u00f3n de los pacientes en funci\u00f3n del momento del d\u00eda en que deben tomarse, de manera que les resulte m\u00e1s f\u00e1cil hacerlo correctamente. Con su utilizaci\u00f3n se busca evitar errores de medicaci\u00f3n y mejorar la adherencia a los tratamientos.<\/span><span style=\"color: #808080;\"><br \/>\n<\/span><\/p>\n<p style=\"text-align: left;\"><strong>Enlaces relacionados:<\/strong><\/p>\n<ul style=\"text-align: left;\">\n<li><a href=\"http:\/\/blog.cofb.cat\/1-doctubre-dia-internacional-de-la-gent-gran-els-farmaceutics-donen-eines-per-millorar-el-seguiment-dels-tractaments\/\" target=\"_blank\" rel=\"noopener\">1 de octubre, D\u00eda Internacional de las Personas Mayores: los farmac\u00e9uticos dan herramientas para mejorar el seguimiento de los tratamientos<\/a> (Blog)<\/li>\n<li><a href=\"http:\/\/blog.cofb.cat\/les-farmacies-catalanes-estudien-monitoritzar-a-pacients-cronics\/\" target=\"_blank\" rel=\"noopener\">Las farmacias catalanas estudian monitorizar a pacientes cr\u00f3nicos<\/a>s (Blog)<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>M\u00e1s de 21.500 personas se benefician en Barcelona de los Sistemas Personalizados de Dosificaci\u00f3n que ofrecen las farmacias. \u00bfQu\u00e9 podr\u00eda aportar la tecnolog\u00eda a estos dispositivos? \u00c9sta es una de las preguntas a las que respondi\u00f3 Eran Shavelsky, fundador y CEO de Medminder, en la entrevista que le hicimos [\u2026]<\/p>","protected":false},"author":1,"featured_media":18393,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2187,2176,2216],"class_list":["post-18318","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-adherencia","tag-cartera-de-serveis","tag-spd"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"M\u00e9s de 21.500 persones es beneficien a Barcelona dels Sistemes Personalitzats de Dosificaci\u00f3 que ofereixen les farm\u00e0cies. Qu\u00e8 hi podria aportar la tecnologia a aquests dispositius? Aquesta \u00e9s una de les preguntes a les que va respondre Eran Shavelsky, fundador i CEO de Medminder, en l\u2019entrevista que li vam fer [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-12-21T13:00:09+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder\",\"datePublished\":\"2015-12-21T13:00:09+00:00\",\"dateModified\":\"2015-12-21T13:00:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/\"},\"wordCount\":376,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"adher\u00e8ncia\",\"cartera de serveis\",\"SPD\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/\",\"name\":\"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-12-21T13:00:09+00:00\",\"dateModified\":\"2015-12-21T13:00:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/","og_locale":"es_ES","og_type":"article","og_title":"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"M\u00e9s de 21.500 persones es beneficien a Barcelona dels Sistemes Personalitzats de Dosificaci\u00f3 que ofereixen les farm\u00e0cies. Qu\u00e8 hi podria aportar la tecnologia a aquests dispositius? Aquesta \u00e9s una de les preguntes a les que va respondre Eran Shavelsky, fundador i CEO de Medminder, en l\u2019entrevista que li vam fer [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-12-21T13:00:09+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder","datePublished":"2015-12-21T13:00:09+00:00","dateModified":"2015-12-21T13:00:09+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/"},"wordCount":376,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#primaryimage"},"thumbnailUrl":"","keywords":["adher\u00e8ncia","cartera de serveis","SPD"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/","url":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/","name":"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-12-21T13:00:09+00:00","dateModified":"2015-12-21T13:00:09+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/12\/21\/que-pot-aportar-la-tecnologia-al-compliment-dels-tractaments-entrevista-a-eran-shavelsky-fundador-de-medminder\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Qu\u00e8 pot aportar la tecnologia al compliment dels tractaments? Entrevista a Eran Shavelsky, fundador de Medminder"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"M\u00e9s de 21.500 persones es beneficien a Barcelona dels Sistemes Personalitzats de Dosificaci\u00f3 que ofereixen les farm\u00e0cies. Qu\u00e8 hi podria aportar la tecnologia a aquests dispositius? Aquesta \u00e9s una de les preguntes a les que va respondre Eran Shavelsky, fundador i CEO de Medminder, en l\u2019entrevista que li vam fer [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/18318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=18318"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/18318\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=18318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=18318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=18318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}